OB/GYN Clinical Alert – October 1, 2004

October 1, 2004

• Special Report: Cesareans for All?

  It is clear that the United States Cesarean section rate (CSR), while tailing off in the late 1990s, is now again rapidly heading upward. What Should be the Ideal CSR? Why the Recent Rise in CSR? Whos Most Apt to Either Offer or Comply with Patient-Requested Cesarean Section?

  Read more

• YKL-40 and Ovarian Cancer

  YKL-40 may represent a novel marker for the detection of early-stage ovarian cancer. YKL-40 levels in early stage patients may also predict disease recurrence and survival. The use of YKL-40 in detection of early stage ovarian cancer deserves further investigation.

  Read more

• Assessing Blood Estradiol Levels

  Vihtamaki and colleagues from Finland measured the circulating levels of estradiol 12 hours after the topical, percutaneous, evening administration of 1.5 mg estradiol (EstroGel) in 10 women who had been using this method of hormone therapy for at least 2 years.

  Read more

• Surgical Staging Of Ovarian Low Malignant Potential Tumors

  Routine pelvic and para-aortic lymph node dissection is not necessary in the majority of women with ovarian low malignant potential tumors.

  Read more

• Notice to Readers . . .

  Read more

• Pharmacology Watch: Linking COX-2 Inhibitors and Cardiovascular Event Risk

  Viagra: Maximum Capacity at High-Altitudes?; FDA Actions.

  Read more

• Clinical Briefs in Primary Care supplement

  Read more